Leflunomide
Leflunomide is indicated for the treatment of adult patients with:
• active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD).
Leflunomide is indicated for the treatment of adult patients with:
• active rheumatoid arthritis as a "disease-modifying antirheumatic drug" (DMARD).
Download the Leflunomide SPC. You will need Adobe Reader to view this document.
Download the Leflunomide SPC. You will need Adobe Reader to view this document.